Skip to main content

Table 4 Liver impairment according to risk factors

From: Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings

   

AST

ALT

ALT + AST

  

N = 306

Abnormal

(N = 144)

Abnormal

(N = 123)

Abnormal

(N = 93)

   

n(%)

n(%)

n(%)

Gender

F

252

120 (47.62)

101(40.08)

73(28.97)

M

54

24(44.44)

22 (40.74)

20(37.04)

p-value

  

0.67

0.93

0.24

Age

< 30

156

55 (35.26)

53 (33,97)

33 (21.15)

[30-50[

111

57 (51.35)

40 (70.17)

33 (29.73)

> 50

39

32 (82.05)

30 (69,24)

27 (69.23)

p-value

  

< 0.001

< 0.001

< 0.001

Matrimonial Status

Célibat

129

51 (39.53)

48(37.21)

30(23.25)

Marié

168

90 (53.57)

72 (42.86)

60(35.71)

Veuve

09

3 (33.33)

3 (33.33)

3 (33.33)

p-value

  

0.06

0.68

0.06

HCV history in the neighborhood

Yes

63

30(47.62)

27(42.86)

19(30.16)

No

243

114(59.26)

96(39.51)

74(30.45)

p-value

  

0.92

0.63

0.96

Alcohol consumption

Yes

228

115(50.44)

100(43.86)

75(32.89)

No

78

29(37.18)

23(29.49)

18(23.08)

p-value

  

0.04

0.03

0.1

History of sexually transmitted infections

Yes

129

62(48.06)

48(37.21)

35(27.13)

No

177

82(46.33)

75(42.37)

58(32.77)

p-value

  

0.76

0.36

0.29

Clinical signs of hepatitis C

Yes

297

139(46.80)

120(40.4)

90(30.30)

 

No

09

5(55.56)

3(33.33)

3(33.33)

p-value

  

0.86

0.93

0.86